CN102232909A - Unsymmetrical dimethylhydrazine resisting nutritional protective cream - Google Patents
Unsymmetrical dimethylhydrazine resisting nutritional protective cream Download PDFInfo
- Publication number
- CN102232909A CN102232909A CN2010101642553A CN201010164255A CN102232909A CN 102232909 A CN102232909 A CN 102232909A CN 2010101642553 A CN2010101642553 A CN 2010101642553A CN 201010164255 A CN201010164255 A CN 201010164255A CN 102232909 A CN102232909 A CN 102232909A
- Authority
- CN
- China
- Prior art keywords
- nutritional
- content
- unsymmetrical dimethylhydrazine
- dimethylhydrazine
- protective cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 15
- RHUYHJGZWVXEHW-UHFFFAOYSA-N 1,1-Dimethyhydrazine Chemical compound CN(C)N RHUYHJGZWVXEHW-UHFFFAOYSA-N 0.000 title abstract description 19
- 239000011252 protective cream Substances 0.000 title abstract 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008367 deionised water Substances 0.000 claims abstract description 6
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 6
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims abstract description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000003408 sphingolipids Chemical class 0.000 claims abstract description 4
- 239000008117 stearic acid Substances 0.000 claims abstract description 4
- 239000006071 cream Substances 0.000 claims description 9
- 230000035764 nutrition Effects 0.000 claims description 9
- 229930003270 Vitamin B Natural products 0.000 claims description 6
- 239000011720 vitamin B Substances 0.000 claims description 6
- 235000019156 vitamin B Nutrition 0.000 claims description 6
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 1
- 238000005202 decontamination Methods 0.000 abstract description 5
- 230000003588 decontaminative effect Effects 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000001804 emulsifying effect Effects 0.000 abstract description 4
- 150000007857 hydrazones Chemical class 0.000 abstract description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 4
- 239000000839 emulsion Substances 0.000 abstract 2
- 239000011726 vitamin B6 Substances 0.000 abstract 2
- 235000019158 vitamin B6 Nutrition 0.000 abstract 2
- 229940011671 vitamin b6 Drugs 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000007599 discharging Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000002688 persistence Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000002429 hydrazines Chemical class 0.000 description 8
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 7
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 2
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- -1 hydrazine compound Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention specifically relates to an unsymmetrical dimethylhydrazine resisting nutritional protective cream. Compared with a gas mask and a decontamination technology, the nutritional protective cream not only has notable effect, but also has advantages in the aspects of safety, persistence, economy and the like. At present, no nutritional protective creams for the unsymmetrical dimethylhydrazine are found at home and abroad, therefore, the invention develops the unsymmetrical dimethylhydrazine resisting nutritional protective cream which can have good application prospects. The preparation method comprises the following steps of: adding hydrophilic components to deionized water, heating to 70 DEG C, fully stirring until swelling fully and uniformly to prevent caking, wherein the emulsifying temperature is about 70-75 DEG C and the homogenizing speed and time are rigidly controlled; adding an essence and an active substance when the temperature is below 50 DEG C, after emulsifying, cooling the emulsion system to near to the room temperature, wherein the discharging temperature depends on the softening temperature of the emulsion system; and filling by a filling machine after storing for 1 day. Proven by many times of tests, the vitamin B6 in the nutritional protective cream can directly react with the unsymmetrical dimethylhydrazine to generate water and hydrazone, thereby eliminating the toxicity of the unsymmetrical dimethylhydrazine. In the product, the vitamin B6 content is not lower than 24.3%, the sphingolipid content is not lower than 0.1%, the octyl dodecanol content is not lower than 10%, the stearic acid content is not lower than 10%, the glycerol content is not lower than 6% and the deionized water is added to 100%.
Description
Affiliated technical field
The present invention relates to a kind of protection type cosmetics, added the bioactive ingredients and the material of opposing uns-dimethylhydrazine damage in these cosmetics, as vitamin B
6, glycerol etc., smear easily and disperse, and on skin, stay successive protecting film, chafe not, with after easily remove, can effectively protect and shield uns-dimethylhydrazine and absorb injury and stimulation human body caused through skin.
Background technology
(unsymmetrical dimethylhydrazine is the main liquid propellant that present large-scale carrier rocket is used UDMH) to uns-dimethylhydrazine, still will equip and use in considerable time from now on.Because it has intensive corrosiveness to skin, and is fat-soluble, very easily absorb through skin, when causing skin burn, penetrate epidermis and enter corium and subcutaneous tissue, be absorbed into blood through blood capillary and lymphatic vessel, cause poisoning.Because anti-Zhiduo County of uns-dimethylhydrazine relates to the tender subject of space flight and military field, little bibliographical information outside the native land.Be limited to the angle of dressing canister respirator and decontamination technology about the Protective Research of being infected with uns-dimethylhydrazine both at home and abroad at present more, less about the research of nutrition protection cream.
U.S.'s uns-dimethylhydrazine leaks decontamination Study on Technology and guided missile cause synchronized development.The research initial stage, the way that adopts big water gaging to wash.Though this method is simple, because hydrazine compound in the flushing water and undecomposed destruction, to underground water source and environment existence harm in various degree., destroy in the serial oxidant that leaks hydrazine fuel for this reason, find that hypochlorite is the best decontaminant that destroys the hydrazine class in research.Hypochlorite is significantly for the decontamination effect of hydrazine class leakage, but also fails thoroughly to solve the hydrazine class steam of leakage to atmospheric pollution problem.To early 1970s, in order to prevent that hydrazine class steam from spreading and prevent to be diffused in airborne hydrazine steam is oxidized to nitrosamine one class by oxygen in the air with serious pollution material in atmosphere, the covering decontaminant begins one's study, after in a single day hydrazine class propellant leaks, adopt the foam coverage agent, the hydrazine class and the hydrazine-containing water that leak are covered, make it isolated, prevent that hydrazine class steam is to Atmospheric Diffusion with air.The U.S. is topped dose of hypochlorite or foam to the decontaminant that hydrazine class small leakage adopts at present.
Vitamin B
6Claim again how hot pyrrole is, is the constituent of some coenzyme in the human body, participates in multiple metabolic response, especially with amino acid metabolism substantial connection arranged.Vitamin B
6Long-term lacking can cause the unify infringement of hemopoietic function of skin, central nervous system.Relate to the enzymatic reaction that many 5-pyridoxal 5-phosphates participate in the nervous system, neurotransmitter levels is raise, comprise 5-hydroxy tryptamine, taurine, dopamine, norepinephrine, histamine and γ-An Jidingsuan.Along with going deep into of studying, find that it is evident in efficacy on central nervous system disease such as treatment Parkinsonism, convulsions spasm in recent years.The generation of these diseases and glutamate decarboxylase and pyridoxal 5-phosphate affinity are low, and central nervous system's alpha-aminobutyric acid content reduces substantial connection.Vitimin supplement B
6After can recover the glutamate decarboxylase activity, correct synthetic, the metabolism disorder of γ-An Jidingsuan, improve the content of γ-An Jidingsuan in the central nervous system, thereby make disappearance of convulsion.Verified energy of uns-dimethylhydrazine in vitro and B
6Congener 2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine. and 5-pyridoxal 5-phosphate be combined into corresponding hydrazone, become hydrazone reaction will clear up uns-dimethylhydrazine.In view of vitamin B
6The important physical function, it can be used as the nutrition protection cream that the important function factor is used for anti-uns-dimethylhydrazine.
Compare with dressing canister respirator and decontamination technology, not only effect is remarkable for nutrition protection cream, and has more the advantage of aspects such as safety, persistency, economy.At present, also not about the nutrition protection cream appearance of uns-dimethylhydrazine, therefore develop a kind of nutrition protection cream of anti-uns-dimethylhydrazine both at home and abroad, good application prospects will be arranged.
Summary of the invention
In order to study the nutrition protection cream that obtains a kind of comparatively economic, simple, safe, practical anti-uns-dimethylhydrazine, the present invention adds hydrophilic composition in the deionized water earlier, is heated to 70 ℃, fully stirs, and makes its full and uniform ground swelling, prevents conglomeration.Emulsifying temperature is about 70～75 ℃, the speed and the time of strict control homogenizing.Be lower than 50 ℃ of interpolation essence and active matters down.After the emulsifying, emulsification system will be cooled near room temperature.Discharge temp depends on the softening temperature of emulsification system.Store that the reuse filling machine fills after 1 day.We prove by test of many times, wherein vitamin B
6Can directly act on uns-dimethylhydrazine, generate water and hydrazone, thereby eliminate the toxicity of uns-dimethylhydrazine.This product vitamin B
6Content is not less than 24.3%, and sphingolipid content is not less than 0.1%, and octyl dodecanol content is not less than 10%, and stearic acid content is not less than 10%, and glycerol content is not less than 6%, and deionized water adds to 100%.
Claims (2)
1. cream is protected in the nutrition of an anti-uns-dimethylhydrazine, with vitamin B
6, sphingolipid, octyl dodecanol, stearic acid, glycerol and deionized water be raw material.
2. according to the nutrition protection cream of right 1 described anti-uns-dimethylhydrazine, it is characterized in that vitamin B
6Content is not less than 24.3%, and sphingolipid content is not less than 0.1%, and octyl dodecanol content is not less than 10%, and stearic acid content is not less than 10%, and glycerol content is not less than 6%, and deionized water adds to 100%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101642553A CN102232909A (en) | 2010-04-30 | 2010-04-30 | Unsymmetrical dimethylhydrazine resisting nutritional protective cream |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101642553A CN102232909A (en) | 2010-04-30 | 2010-04-30 | Unsymmetrical dimethylhydrazine resisting nutritional protective cream |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102232909A true CN102232909A (en) | 2011-11-09 |
Family
ID=44884336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101642553A Pending CN102232909A (en) | 2010-04-30 | 2010-04-30 | Unsymmetrical dimethylhydrazine resisting nutritional protective cream |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102232909A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104146269A (en) * | 2014-07-28 | 2014-11-19 | 苏喜生 | Food additive for resisting stress of unsymmetrical dimethylhydrazine and preparation method of food additive |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1252987A (en) * | 1998-11-03 | 2000-05-17 | 莱雅公司 | Fading preventive dressing method and composition and assembly box used for implementing said method |
| CN101431995A (en) * | 2006-02-21 | 2009-05-13 | 玫琳凯有限公司 | Stable vitamin C compositions |
-
2010
- 2010-04-30 CN CN2010101642553A patent/CN102232909A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1252987A (en) * | 1998-11-03 | 2000-05-17 | 莱雅公司 | Fading preventive dressing method and composition and assembly box used for implementing said method |
| CN101431995A (en) * | 2006-02-21 | 2009-05-13 | 玫琳凯有限公司 | Stable vitamin C compositions |
Non-Patent Citations (3)
| Title |
|---|
| 张捷等: "维生素B6在肼类火箭推进剂中毒救治中的应用", 《药学实践杂志》 * |
| 杨蓉等: "偏二甲肼的毒理及安全防护", 《2004年第三届环境与职业医学国际学术研讨会论文集》 * |
| 王晓峰等: "系数倍率法测定维生素B6霜含量", 《中国医院药学杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104146269A (en) * | 2014-07-28 | 2014-11-19 | 苏喜生 | Food additive for resisting stress of unsymmetrical dimethylhydrazine and preparation method of food additive |
| CN104146269B (en) * | 2014-07-28 | 2015-08-19 | 苏喜生 | A kind of for anti-uns-dimethylhydrazine stress food additives and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jovanovic et al. | Antioxidant potential of gallocatechins. A pulse radiolysis and laser photolysis study | |
| ES2752030T3 (en) | Ketone bodies to protect tissues from damage by ionizing radiation | |
| JP4864158B2 (en) | Method for producing functional gel | |
| JP4672084B1 (en) | Method for producing functional gel | |
| CN110507551B (en) | Preparation method of permeation-promoting anti-wrinkle essence preparation containing acetyl hexapeptide-8 | |
| Bian et al. | Tumor microenvironment‐activated nanocomposite for self‐amplifying chemodynamic/starvation therapy enhanced Ido‐blockade tumor immunotherapy | |
| CN107496186A (en) | A kind of Kaempferol nano-composition and its preparation method and application | |
| CN102232909A (en) | Unsymmetrical dimethylhydrazine resisting nutritional protective cream | |
| ES8900197A1 (en) | PROCEDURE FOR THE PREPARATION OF LIPOSOMES FROM A MIXTURE OF A LIPID COMPONENT AND WATER | |
| CN108938674A (en) | Purposes of the Lyopgized Nocardia rubra-cell Wall Skeleton in preparation treatment cutaneous lesions drug | |
| US8007786B2 (en) | Radioprotective SOD soluble isoform and uses thereof | |
| KR102120416B1 (en) | Composition comprising high concentration caffeines | |
| EP2692348A1 (en) | Antitumor agent containing carbon dioxide as active ingredient | |
| CN101669480A (en) | Pesticide water emulsion and preparation method thereof | |
| Chaurasiya et al. | Natural product-loaded lipid-based nanocarriers for skin cancer treatment: An overview | |
| JP2012050898A (en) | Method for producing functional gel | |
| CN105456182A (en) | Topical cream for treating fungal infection and production method thereof | |
| CN102232908A (en) | Nutritional protection cream for resisting dinitrogen tetroxide | |
| CN109486681A (en) | The preparation method and applications of bacterial lysate and D. radiodurans extract | |
| Ghafghazi et al. | Chlorpromazine and epinephrine hyperglycemic mechanisms | |
| CN104906562A (en) | Application of lauric acid modified SOD on prevention of chronic radiation skin lesion | |
| CN101810565A (en) | Tolterodine gel preparation and preparation method thereof | |
| Philpot et al. | A comparison between the effects in mice of injected organic peroxides and of whole-body x-irradiation | |
| CN105168208B (en) | A kind of external drug brought down a fever and prevented heatstroke and lower the temperature of bringing down a fever | |
| CN109350566A (en) | A kind of deep layer reparation concentration essence dew |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111109 |